Pacific Edge US lab completed

ALAN WOOD
Last updated 11:16 17/10/2012
PEB 0.490 0.00 0.00%
PEB

Click for a detailed chart

Relevant offers

Industries

Visible cartons allowed in alcohol area Failure to build Waimea Dam would put 75 jobs 'in jeopardy' European Union fines Google a record $3.55 billion for antitrust breaches Toss the carpark vistas, designer urges Hamilton ANZ $32 million out of pocket from Pumpkin Patch collapse Hosting the America's Cup would bring profile and visitors to New Zealand Reserve Bank: success relies on getting messages across NZ King Salmon forecasts over $20 million in earnings for 2017 Fuji Xerox New Zealand resolving past issues it does not want to see again Farmers demand answers after oyster parasite escapes Marlborough quarantine

Shares in Pacific Edge rose today as it announced it has completed its US$3.7 million (NZ$4.5m) laboratory in the United States on-schedule and within budget.

Pacific Edge is forecasting more than $100m of gross revenues from its US operations in the five years after the new Hershey, Pennsylvania base starts processing in March.

So far the NZX-listed cancer diagnostic company's revenues remain very small and were not disclosed in its year to March 31, 2012 result.

In morning trade Pacific Edge shares were 3 cents or 7.5 per cent higher at 43 cents.

New Zealand chief executive David Darling today said Pacific Edge was now preparing for US registration under the clinical laboratory improvement amendments regulations.

The purpose-built laboratory in Hershey was expected to complete regulatory approval and be fully operational in March 2013 to offer Pacific Edge's bladder cancer diagnostic test.

Pacific Edge is investing in the commercialisation of its Cxbladder product, a diagnostic test for the detection of bladder cancer. It is offering the cancer laboratory test to clinicians throughout the US.

Darling said the laboratory, with a capacity of 260,000 tests a year, would be operated by a wholly owned subsidiary of the company, Pacific Edge Diagnostics USA Limited.

"The demanding timetable to launch this business is being met and the focus of the US team led by Jackie Walker is now on completion of the regulatory approvals, sales force deployment and marketing roll-out."

The US was the world's largest healthcare market, with its 17,000 urologists making it Pacific Edge's most important market, he added.

Ad Feedback

- BusinessDay.co.nz

Special offers

Featured Promotions

Sponsored Content